Page last updated: 2024-09-05

lu 135252 and Colitis

lu 135252 has been researched along with Colitis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Anderson, T; Buhr, HJ; Kruschewski, M; Loddenkemper, C	1

Other Studies

1 other study(ies) available for lu 135252 and Colitis

Article	Year
Endothelin-1 receptor antagonist (LU-135252) improves the microcirculation and course of TNBS colitis in rats. Digestive diseases and sciences, 2006, Volume: 51, Issue:8 Topics: Animals; Blood Flow Velocity; Capillary Permeability; Colitis; Colon; Disease Models, Animal; Endothelin A Receptor Antagonists; Male; Microcirculation; Phenylpropionates; Pyrimidines; Rats; Rats, Sprague-Dawley; Treatment Outcome; Trinitrobenzenesulfonic Acid	2006

Article

Year

Endothelin-1 receptor antagonist (LU-135252) improves the microcirculation and course of TNBS colitis in rats.

Digestive diseases and sciences, 2006, Volume: 51, Issue:8

Topics: Animals; Blood Flow Velocity; Capillary Permeability; Colitis; Colon; Disease Models, Animal; Endothelin A Receptor Antagonists; Male; Microcirculation; Phenylpropionates; Pyrimidines; Rats; Rats, Sprague-Dawley; Treatment Outcome; Trinitrobenzenesulfonic Acid

2006